English

China Bio-Immunity CORP

EDGAR

Quarterly report (10-Q) · filed 2008-11-14

14 filing records in this dataset, filed from 2006-05-11 to 2008-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

9.6 million USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 9599685 USD Source

Operating margin

62.2%

2008-09-30 · %

Exact inputs and evidence

Operating Income: 5971168 USD Source
Revenue: 9599685 USD Source

Cash and cash equivalents: 13.9 million USD 2008-09-30 Source
Exact value

13946737 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-23.1 thousand USD

2007-07-01 – 2008-06-30

Exact inputs and evidence

Operating cash flow: -3576 USD · 2007-07-01 – 2007-09-30 Source
Operating cash flow: -17543 USD · 2007-07-01 – 2007-12-31 Source
Operating cash flow: -3576 USD · 2007-07-01 – 2007-09-30 Source
Operating cash flow: -2506 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -5597 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -2506 USD · 2008-01-01 – 2008-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-14.

Financial data available through: 2007-06-30.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2007-06-30
operating income: No compatible figures in this window
Net income: 3 of 11 periods available· newest 2007-06-30
Operating cash flow: 3 of 11 periods available· newest 2007-06-30
capital expenditure: No compatible figures in this window
Total assets: 3 of 11 periods available· newest 2007-06-30
Total liabilities: 3 of 11 periods available· newest 2007-06-30
Current assets: 3 of 11 periods available· newest 2007-06-30
Current liabilities: 3 of 11 periods available· newest 2007-06-30
Cash and cash equivalents: 3 of 11 periods available· newest 2007-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+338.5%

Prior period

USD 187

2005-07-01 – 2006-06-30
Current period

USD 820

2006-07-01 – 2007-06-30

Exact inputs and evidence

820 − 187 = 633 USD

187 USD · 2005-07-01 – 2006-06-30
Inspect prior input Prior source
820 USD · 2006-07-01 – 2007-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · China Bio-Immunity CORP · 2007-06-30 China Bio-Immunity CORP (edgar:1345479) Year-over-year change in Revenue: 633 USD Concept: fundies:Revenue Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 820 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1012 Input fundies:Revenue: 187 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1012
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3,337

Prior period

−USD 22,474

2005-07-01 – 2006-06-30
Current period

−USD 25,811

2006-07-01 – 2007-06-30

Exact inputs and evidence

-25811 − -22474 = -3337 USD

-22474 USD · 2005-07-01 – 2006-06-30
Inspect prior input Prior source
-25811 USD · 2006-07-01 – 2007-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · China Bio-Immunity CORP · 2007-06-30 China Bio-Immunity CORP (edgar:1345479) Year-over-year change in Net income: -3337 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -25811 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1277 Input fundies:NetIncome: -22474 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1277
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 10,454

Prior period

−USD 19,809

2005-07-01 – 2006-06-30
Current period

−USD 30,263

2006-07-01 – 2007-06-30

Exact inputs and evidence

-30263 − -19809 = -10454 USD

-19809 USD · 2005-07-01 – 2006-06-30
Inspect prior input Prior source
-30263 USD · 2006-07-01 – 2007-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · China Bio-Immunity CORP · 2007-06-30 China Bio-Immunity CORP (edgar:1345479) Year-over-year change in Operating cash flow: -10454 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -30263 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1315 Input fundies:OperatingCashFlow: -19809 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1315
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2006-07-01 – 2007-06-30

Revenue USD 820 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 25,811 −3,148% of revenue

Cash

Operating cash flow −USD 30,263 −3,691% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2004-07-01 – 2005-06-30	0	Unavailable	Unavailable	Unavailable	-3930	Unavailable	Source 2004-07-01 – 2005-06-30: 0 USD Inspect Revenue Open source 2004-07-01 – 2005-06-30: -3930 USD Inspect Net Income Open source 2004-07-01 – 2005-06-30: -3152 USD Inspect Operating Cash Flow Open source
2006 2005-07-01 – 2006-06-30	187	Unavailable	Unavailable	Unavailable	-22474	Unavailable	Source 2005-07-01 – 2006-06-30: 187 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: -22474 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: -19809 USD Inspect Operating Cash Flow Open source
2007 2006-07-01 – 2007-06-30	820	Unavailable	Unavailable	Unavailable	-25811	Unavailable	Source 2006-07-01 – 2007-06-30: 820 USD Inspect Revenue Open source 2006-07-01 – 2007-06-30: -25811 USD Inspect Net Income Open source 2006-07-01 – 2007-06-30: -30263 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 820 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-06-30	Revenue	0	Revenue: 0 Open source
20062006-06-30	Revenue	187	Revenue: 187 Open source
20072007-06-30	Revenue	820	Revenue: 820 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

338.5% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-06-30	Year over year	No prior comparable period	Revenue: 0 Open source
20062006-06-30	Year over year	No prior comparable period	Revenue: 187 Open source Revenue: 0 Open source
20072007-06-30	Year over year	338.5%	Revenue: 820 Open source Revenue: 187 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -3,147.7% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2005-06-30	Operating margin	Not reported	Revenue: 0 Open source
2006-06-30	Operating margin	Not reported	Revenue: 187 Open source
2007-06-30	Operating margin	Not reported	Revenue: 820 Open source
20052005-06-30	Net margin	Not reported	Net Income: -3930 Open source Revenue: 0 Open source
20062006-06-30	Net margin	-12,018.2%	Net Income: -22474 Open source Revenue: 187 Open source
20072007-06-30	Net margin	-3,147.7%	Net Income: -25811 Open source Revenue: 820 Open source
20052005-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -3152 Open source
20062006-06-30	Free cash flow margin	Not reported	Revenue: 187 Open source Operating Cash Flow: -19809 Open source
20072007-06-30	Free cash flow margin	Not reported	Revenue: 820 Open source Operating Cash Flow: -30263 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -30.3K 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-06-30	Operating cash flow	-3152	Operating Cash Flow: -3152 Open source
20062006-06-30	Operating cash flow	-19809	Operating Cash Flow: -19809 Open source
20072007-06-30	Operating cash flow	-30263	Operating Cash Flow: -30263 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-06-30	Free cash flow	Unavailable	Operating Cash Flow: -3152 Open source
20062006-06-30	Free cash flow	Unavailable	Operating Cash Flow: -19809 Open source
20072007-06-30	Free cash flow	Unavailable	Operating Cash Flow: -30263 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

752.6% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-06-30	Liabilities / assets	83.5%	Total Liabilities: 3651 Open source Total Assets: 4371 Open source
20062006-06-30	Liabilities / assets	397.1%	Total Liabilities: 29077 Open source Total Assets: 7323 Open source
20072007-06-30	Liabilities / assets	752.6%	Total Liabilities: 54854 Open source Total Assets: 7289 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.07× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-06-30	Current assets / current liabilities	0.05×	Current Assets: 186 Open source Current Liabilities: 3651 Open source
20062006-06-30	Current assets / current liabilities	0.12×	Current Assets: 3486 Open source Current Liabilities: 29077 Open source
20072007-06-30	Current assets / current liabilities	0.07×	Current Assets: 3916 Open source Current Liabilities: 54854 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2004-07-01 – 2005-06-30	−USD 3,930 Exact value Exact value: -3930 USD 2004-07-01 – 2005-06-30: -3930 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Bio-Immunity CORP · 2005-06-30 China Bio-Immunity CORP (edgar:1345479) Net Income: -3930 USD Concept: fundies:NetIncome Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479/explain?concept=fundies%3ANetIncome&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:NetIncome: -3930 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-06-000285.txt#2424 The citation records this snapshot. The page link may show a newer release later.	−USD 3,152 Exact value Exact value: -3152 USD 2004-07-01 – 2005-06-30: -3152 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Bio-Immunity CORP · 2005-06-30 China Bio-Immunity CORP (edgar:1345479) Operating Cash Flow: -3152 USD Concept: fundies:OperatingCashFlow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479/explain?concept=fundies%3AOperatingCashFlow&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3152 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-06-000285.txt#2436 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2005-07-01 – 2006-06-30	−USD 22,474 Exact value Exact value: -22474 USD 2005-07-01 – 2006-06-30: -22474 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Bio-Immunity CORP · 2006-06-30 China Bio-Immunity CORP (edgar:1345479) Net Income: -22474 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: -22474 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1277 The citation records this snapshot. The page link may show a newer release later.	−USD 19,809 Exact value Exact value: -19809 USD 2005-07-01 – 2006-06-30: -19809 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Bio-Immunity CORP · 2006-06-30 China Bio-Immunity CORP (edgar:1345479) Operating Cash Flow: -19809 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19809 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1315 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2006-07-01 – 2007-06-30	−USD 25,811 Exact value Exact value: -25811 USD 2006-07-01 – 2007-06-30: -25811 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Bio-Immunity CORP · 2007-06-30 China Bio-Immunity CORP (edgar:1345479) Net Income: -25811 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: -25811 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1277 The citation records this snapshot. The page link may show a newer release later.	−USD 30,263 Exact value Exact value: -30263 USD 2006-07-01 – 2007-06-30: -30263 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Bio-Immunity CORP · 2007-06-30 China Bio-Immunity CORP (edgar:1345479) Operating Cash Flow: -30263 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1345479/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30263 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1345479/0001010412-07-000249.txt#1315 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

14 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001345479, 1345479, edgar:1345479

Also known as Easy Golf CORP

China Bio-Immunity CORP

Latest quarter

Revenue

Operating margin

Trailing twelve months

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2007 2006-07-01 – 2007-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation